26 maio 2020
Portugal - Telecoms, Mobile and Broadband - Statistics and Analyses: BuddeComm notes that the outbreak of the Coronavirus in 2020 is having a significant impact on production and supply chains globally. During the coming year the telecoms sector to various degrees is likely to experience a downturn in mobile device production, while it may also be difficult for network operators to manage workflows when maintaining and upgrading existing infrastructure. Overall progress towards 5G may be postponed or slowed down in some countries
EU Quest for COVID-19 Apps, A Blow to GDPR and Digital Sovereignty: Europe should focus on digital transformation by investing in the talent and technology necessary to emerge from the pandemic crisis more competitive and resilient, and with a regulatory environment that strikes a better balance between the individual benefits of privacy and the collective benefits of gathering and sharing data.
The pandemic has changed how we think about the privilege of mobility: Governments around the world have advised people to self-isolate, but who is able to follow this advice? In the United States, it is largely the richest 25 percent who can work from home. As the New York Times observed weeks ago, the middle class’ swift shift to virtual life has been striking. White-collar workers at large companies are likely to be some of the last to return to the office, if they do so at all. They may even be thriving at home, finding previously elusive downtime and investing in new hobbies.
Here’s how long coronavirus patients are contagious, according to multple studies: Researchers from Singapore say a patient isn’t infectious 11 days after the onset of symptoms, citing similar research from other countries.
Subscrever:
Comentários (Atom)
-
The dangers of Covid-19 far outweigh the risks of a vaccine : So can I tell you that there won't be a long-term unknown side effect to t...
-
The Value of a Cure: An Asset Pricing Perspective : We provide an estimate of the value of a cure using the joint behavior of stock prices ...
-
The Oxford/AstraZeneca Vaccine Efficacy Data : We’re going to have to wait and collect more data to be able to say anything about these, fo...